← back to search

Zhikun Liu

Hebei Medical University · CN
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Esophageal Cancer Research and Treatment, Lung Cancer Diagnosis and Treatment, Hepatocellular Carcinoma Treatment and Prognosis, and Radiomics and Machine Learning in Medical Imaging.
h-index
27
citations
2,377
works
188
NIH funding
primary concept
email

Recent publications

PD-L1 monoclonal antibody alleviated MI injury of left ventricular function via modulating CD47/SHP2/SIRPα/SYK/FcγR signalings in tumor associated macrophages
Scientific Reports 2025cited by 2position: middledoi
Development and validation of an interpretable machine learning model for acute radiation dermatitis in breast cancer
Frontiers in Oncology 2025cited by 1position: lastdoi
[Expression of Concern] Radiosensitization of esophageal carcinoma cells by knockdown of RNF2 expression
International Journal of Oncology 2025cited by 0position: middledoi
Single-cell RNA sequencing analysis reveals the role of TXNDC5 in keloid formation
CytoJournal 2024cited by 2position: firstdoi
Circ_0008500 Knockdown Improves Radiosensitivity and Inhibits Tumorigenesis in Breast Cancer Through the miR-758-3p/PFN2 Axis
Journal of Mammary Gland Biology and Neoplasia 2022cited by 10position: middledoi
A new pathological assessment method to assess residual lesions after neoadjuvant chemotherapy for breast cancer, residual disease in breast and nodes combined with Ki-67 (RDBN-K)
Translational Breast Cancer Research 2022cited by 0position: middledoi
Can internal mammary lymph nodes irradiation bring survival benefits for breast cancer patients? A systematic review and meta-analysis of 12,705 patients in 12 studies
Radiation Oncology 2021cited by 15position: middledoi
The Influence of KDR Genetic Variation on the Efficacy and Safety of Patients With Advanced NSCLC Receiving First-Line Bevacizumab Plus Chemotherapy Regimen
Technology in Cancer Research & Treatment 2021cited by 14position: middledoi
Influence of VEGFR2 gene polymorphism on the clinical outcomes of apatinib for patients with chemotherapy–refractory extensive-stage SCLC: a real-world retrospective study
International Journal of Clinical Oncology 2021cited by 6position: middledoi
Phosphorylation of PED/PEA‑15 at Ser116 and phosphorylation of p27 at Thr187 indicates a poor prognosis in hepatocellular carcinoma
Oncology Letters 2021cited by 6position: middledoi
Prediction of Locoregional Recurrence-Free Survival of Oesophageal Squamous Cell Carcinoma After Chemoradiotherapy Based on an Enhanced CT-Based Radiomics Model
Frontiers in Oncology 2021cited by 5position: middledoi
Abstract PS6-29: A new pathological assessment method to assess residual lesions after neoadjuvant chemotherapy for breast cancer: Residual disease in breast and nodes combined with Ki-67 (RDBN-K)
Cancer Research 2021cited by 0position: middledoi
A Nomogram Model Based on Enhanced CT Radiomics Features for Predicting Tumor Response to Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma
Research Square 2021cited by 0position: middledoi
The value of ultrasound in diagnosing metastatic internal mammary lymph nodes in preoperative breast cancer
Gland Surgery 2020cited by 5position: middledoi
LncRNA-ATB Can Be a Biomarker for Diagnosis and Prognosis Evaluation of Non-Small Cell Lung Cancer
ONCOLOGIE 2020cited by 0position: middledoi
Clinical practice guidelines on liver transplantation for hepatocellular carcinoma in China (2018 edition)
Hepatobiliary & pancreatic diseases international 2019cited by 51position: middledoi
Dosimetric Predictors of Radiation Gastritis Due to Postoperative Intensity Modulated Irradiation Therapy in Patients with Esophageal Squamous Cell Carcinoma After Radical Esophagectomy
Cancer Biotherapy and Radiopharmaceuticals 2019cited by 4position: lastdoi
The effect of RNF2 knockdown on the radiosensitivity in transplanted tumor of nude mice of esophageal carcinoma in vivo
Zhonghua fangshe zhongliuxue zazhi 2019cited by 0position: middledoi
Effect of different expression levels of USP28 on apoptosis and related protein expression in esophageal cancer cell ECA109 after irradiation
Zhonghua fangshe zhongliuxue zazhi 2019cited by 0position: middledoi
Abdominal lymph node recurrence after radical surgery in patients with middle thoracic esophageal squamous cell carcinoma: risk factors and guidance for postoperative radiotherapy
Zhonghua fangshe zhongliuxue zazhi 2018cited by 1position: middledoi
Failure patterns of radical surgery in patients with T1-4N0-1M0 thoracic esophageal squamous cell carcinoma: implications for the target area design of postoperative therapy
Zhonghua fangshe yixue yu fanghu zazhi 2018cited by 0position: middledoi
Efficacy of postoperative chemoradiotherapy after radical resection of squamous cell carcinoma of upper thoracic esophagus
Zhonghua fangshe yixue yu fanghu zazhi 2018cited by 0position: middledoi
Comparison of different treatment modalities in node-positive patients after radical resection for squamous cell carcinoma of the thoracic esophagus
Zhonghua fangshe zhongliuxue zazhi 2018cited by 0position: middledoi
BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway
Oncology Reports 2017cited by 13position: middledoi
Analysis of postoperative failure in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma and consideration of postoperative radiotherapy
Zhonghua fangshe zhongliuxue zazhi 2017cited by 1position: middledoi
Analysis of postoperative failure model in patients with stage pN0 esophageal squamous cell carcinoma and its effect on postoperative radiotherapy
Zhonghua fangshe yixue yu fanghu zazhi 2017cited by 0position: middledoi
Effect of postoperative adjuvant therapy on the prognosis of patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma: a preliminary analysis
Zhonghua fangshe zhongliuxue zazhi 2017cited by 0position: middledoi
Effect of BMI-1 on radiosensitization of esophageal carcino-ma cells after silencing of BMI-1 gene
Zhonghua fangshe zhongliuxue zazhi 2017cited by 0position: middledoi
Therapeutic efficacy of different adjuvant modalities in thoracic esophageal squamous cell carcinoma
Zhonghua fangshe zhongliuxue zazhi 2017cited by 0position: middledoi
Effect of lentivirus-mediated expression of RNF2 gene on the proliferation and migration of esophageal carcinoma cells following X-ray radiotherapy
Zhonghua fangshe zhongliuxue zazhi 2017cited by 0position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Jingwei Su · Hebei Medical University24 papers (2012–2020)Shuchai Zhu · Hebei Medical University20 papers (2012–2021)Wenbin Shen · Henan Institute of Technology20 papers (2012–2019)Youmei Li · Hebei Medical University19 papers (2012–2019)Hongmei Gao · Duke University17 papers (2013–2019)Shuchai Zhu · Hebei Medical University12 papers (2012–2025)Shuchai Zhu · Hebei Medical University11 papers (2012–2019)Wenbin Shen · Capital Medical University9 papers (2012–2017)Shuguang Li · Peking University9 papers (2015–2019)Jingwei Su · Hebei Medical University8 papers (2012–2021)Xingxiao Yang · Hebei Medical University8 papers (2016–2025)Juan Li · Dongfeng Motor Group (China)7 papers (2014–2019)Yankun Cao · North China University of Water Resources and Electric Power7 papers (2012–2016)Juan Li · Central South University6 papers (2012–2018)Teng Li · Xi'an Medical University6 papers (2017–2018)Shuguang Li · Hebei Medical University6 papers (2015–2018)Juan Li · Life University5 papers (2012–2017)Meixiang Sang · Shanghai University of Electric Power4 papers (2016–2025)Yuxiang Wang · Hebei Medical University4 papers (2012–2015)Juan Li · Sun Yat-sen University4 papers (2014–2018)